Last Friday, the 16th, during a question and answer session at the Dôme de Paris, the billionaire Elon Musk announced its plans to hold the first human brain implant still this year.
The reveal came in response to a question posed by a child and his father, demonstrating the interest and curiosity surrounding this innovative technology.
see more
Young people in a regime of prison semi-liberty will be able to have access to…
Fly for less: Government rules allow airfare for R$…
With this initiative, Musk seeks to advance in the field of brain-computer interface, paving the way for new possibilities in the treatment of neurological conditions and in the improvement of communication between brain and machine.
The wait around this milestone is high, while the scientific community and the general public await with interest the developments in this promising area of research.
In a way, the businessman reassured those who might be worried about the technology. Neuralink, mentioning that the process will be gradual and careful.
Meet Neuralink, Elon Musk's company
In May, Neuralink, the neurotechnology company founded by Elon Musk, obtained authorization from the Food and Drug Administration (FDA) to conduct the first clinical study on humans humans.
This approval marks an important beginning in the development of Neuralink's technology and paves the way for advanced research and potential advancements in the field of brain-computer interface.
Neuralink expressed its acceptance and recognition of the hard work done by the team in collaboration with the FDA, highlighting the importance of this initial milestone for the advancement of technology and its ability to help a large number of people.
The company highlighted that this achievement represents a significant step towards the goal of develop innovative solutions to improve the quality of life of people who have lost the ability to communication.
Lover of movies and series and everything that involves cinema. An active curious on the networks, always connected to information about the web.